Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02610361
Recruitment Status : Completed
First Posted : November 20, 2015
Last Update Posted : July 19, 2019
Sponsor:
Information provided by (Responsible Party):
BeiGene

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2017
Actual Study Completion Date : October 2017